Kreatech Diagnostics Raises €2 Million

Kreatech Diagnostics, a Dutch molecular diagnostics startup, has raised €2 million in new VC funding. Alafi Capital was joined by return backer LSP. The company also named Kees Moonen, former CEO of Green Cross Vaccine, as its new CEO.

27 November 2009•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail